Cikkek nyilvánosan hozzáférhető megbízással - Silvia Jimenez-JorgeTovábbi információ
Sehol sem hozzáférhető: 2
Epidemiology of the 2009 influenza pandemic in spain. the spanish influenza surveillance system
AL Cámara, S Jiménez-Jorge, S de Mateo Ontañón, FP Sánchez, ...
Enfermedades Infecciosas y Microbiología Clínica 30, 2-9, 2012
Megbízások: Government of Spain
Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010–2014
S Jiménez-Jorge, F Pozo, A Larrauri, cycEVA Study Team
Vaccine 33 (29), 3276-3280, 2015
Megbízások: Government of Spain
Valahol hozzáférhető: 39
Influenza surveillance in Europe: establishing epidemic thresholds by the moving epidemic method
T Vega, JE Lozano, T Meerhoff, R Snacken, J Mott, R Ortiz de Lejarazu, ...
Influenza and other respiratory viruses 7 (4), 546-558, 2013
Megbízások: Government of Spain
Low and decreasing vaccine effectiveness against influenza A (H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study
E Kissling, M Valenciano, A Larrauri, B Oroszi, JM Cohen, B Nunes, ...
Megbízások: Government of Spain
Influenza surveillance in E urope: comparing intensity levels calculated using the moving epidemic method
T Vega, JE Lozano, T Meerhoff, R Snacken, J Beauté, P Jorgensen, ...
Influenza and other respiratory viruses 9 (5), 234-246, 2015
Megbízások: Government of Spain
Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies
M Darvishian, MJ Bijlsma, E Hak, ER Van Den Heuvel
The Lancet Infectious Diseases 14 (12), 1228-1239, 2014
Megbízások: US National Institutes of Health, Government of Spain
I-MOVE multicentre case–control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
E Kissling, B Nunes, C Robertson, M Valenciano, A Reuss, A Larrauri, ...
Eurosurveillance 21 (16), 2016
Megbízások: Government of Spain
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
A Pérez-Gómez, J Vitallé, C Gasca-Capote, A Gutierrez-Valencia, ...
Cellular & Molecular Immunology 18 (9), 2128-2139, 2021
Megbízások: Government of Spain
Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016
EK Broberg, M Waris, K Johansen, R Snacken, P Penttinen, EIS Network
Eurosurveillance 23 (5), 17-00284, 2018
Megbízások: US National Institutes of Health
Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case–control study, influenza season 2012/13
E Kissling, M Valenciano, U Buchholz, A Larrauri, JM Cohen, B Nunes, ...
Robert Koch-Institut, Infektionsepidemiologie, 2014
Megbízások: Government of Spain
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study
OA Cornely, JM Cisneros, J Torre-Cisneros, MJ Rodríguez-Hernández, ...
Journal of Antimicrobial Chemotherapy 75 (3), 618-627, 2020
Megbízások: European Commission
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A (H1N1) pdm09, B and drifted A (H3N2), I …
M Valenciano, E Kissling, A Reuss, C Rizzo, A Gherasim, JK Horváth, ...
Robert Koch-Institut, Infektionsepidemiologie, 2016
Megbízások: US National Institutes of Health, Government of Spain
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority …
JM Cisneros, CM Rosso-Fernández, C Roca-Oporto, G De Pascale, ...
Critical Care 23, 1-13, 2019
Megbízások: Government of Spain
The European I-MOVE Multicentre 2013–2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A (H1N1) pdm09 and heterogenous results by country …
M Valenciano, E Kissling, A Reuss, S Jiménez-Jorge, JK Horváth, ...
Vaccine 33 (24), 2813-2822, 2015
Megbízások: US National Institutes of Health, Government of Spain
Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12
E Kissling, M Valenciano, S Jimenez-Jorge, S Mateo-Ontañon, ...
European Centre for Disease Prevention and Control (ECDC), 2012
Megbízások: Government of Spain
Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case–control study, 2012/13
M Valenciano, E Kissling
Robert Koch-Institut, Infektionsepidemiologie, 2013
Megbízások: Government of Spain
Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination
S Jiménez-Jorge, S de Mateo, C Delgado-Sanz, F Pozo, I Casas, ...
BMC Infectious diseases 13, 1-12, 2013
Megbízások: Government of Spain
Effectiveness of the 2010–11 seasonal trivalent influenza vaccine in Spain: cycEVA study
S Jiménez-Jorge, C Savulescu, F Pozo, S De Mateo, I Casas, J Ledesma, ...
Vaccine 30 (24), 3595-3602, 2012
Megbízások: Government of Spain
Influenza-related mortality in Spain, 1999-2005
T López-Cuadrado, S Mateo, S Jiménez-Jorge, C Savulescu, A Larrauri
Gaceta Sanitaria 26, 325-329, 2012
Megbízások: Government of Spain
Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012
S Jimenez-Jorge, S Mateo-Ontañon, F Pozo Sanchez, I Casas Flecha, ...
European Centre for Disease Prevention and Control (ECDC), 2012
Megbízások: Government of Spain
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.